Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension
Angiotensin and the Coronavirus | Science | AAAS
Angiotensin-converting enzyme in innate and adaptive immunity | Nature Reviews Nephrology
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | Nature Reviews Cardiology
Do Studies With ACE N- and C-Domain–Selective Inhibitors Provide Evidence for a Non-ACE, Non-Chymase Angiotensin II–Forming Pathway? | Circulation Research
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
IJMS | Free Full-Text | Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse
Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors | PLOS ONE
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 | SpringerLink
Angiotensin-converting enzyme 2 - Wikipedia
An ACE structure | Nature Structural & Molecular Biology
ACE and ACE2 in Inflammation: A Tale of Two Enzymes | Bentham Science
Angiotensin-Converting Enzyme II in the Heart and the Kidney | Circulation Research
Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters | Bentham Science
Pathways: ACE Inhibitor Pathway | www.antibodies-online.com
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries | Hypertension
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? | Hypertension Research
Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers - Lundström - 2021 - Journal of Medical Virology - Wiley Online Library
Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans | Journal of Human Hypertension
Angiotensin-konvertierendes Enzym aus Kaninchenlunge ≥2.0 units/mg protein (modified Warburg-Christian) | Sigma-Aldrich
Frontiers | Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) | Journal of Clinical Pathology
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Figure 1 | Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension
